Novavax Inc

Stock Chart, Company Information, and Scan Results

$10.22(as of Jun 3, 3:57 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Novavax Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$10.22
Ticker SymbolNVAX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees749
CountyUSA
Market Cap$1,678.9M

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax Inc In Our Stock Scanner

As of Jun 04, 2026
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.